ClinicalTrials.Veeva

Menu

Influence of Preop Fibrinogen on Blood in Pediatric Cardiac Surgery

C

CHU Brugmann University Hospital

Status

Completed

Conditions

Cardiac Surgery
Fibrinogenemia
Cardiopulmonary Bypass
Congenital Heart Disease

Treatments

Procedure: Congenital cardiac surgery

Study type

Observational

Funder types

Other

Identifiers

NCT05525195
card_ped_fibri

Details and patient eligibility

About

Fibrinogen plays an important role in the coagulation cascade. Low levels of preoperative fibrinogen have been associated in adults with higher blood and transfusion requirements during surgery. Guidelines from the European Society of Anesthesiology and Intensive Care recommends fibrinogen substitution based on viscoelastic tests in adult cardiac surgery. Cardiopulmonary bypass results in a profound hemodilution and dilution of all coagulation factors. This is especially true in children where the priming volume of the cardiopulmonary bypass circuit is much higher compared to the patient's weight than in adults. Cardiopulmonary bypass generates high levels of tissue plasminogen activator resulting in a hyperfibrinolysis, further lowering fibrinogen levels.

The aim of this retrospective study is to explore a possible relationship between preoperative fibrinogen levels and perioperative blood loss, as well as transfusion requirements in children undergoing cardiac surgery.

Enrollment

932 patients

Sex

All

Ages

Under 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all children with cardiac surgery under cardiopulmonary bypass between 2008 and 2018
  • Age < 16 year

Exclusion criteria

  • preoperative coagulopathy
  • Jehovah's witnesses
  • patients with fresh frozen plasma in the priming of the cardiopulmonary bypass circuit

Trial contacts and locations

1

Loading...

Central trial contact

Denis Schmartz, MD; Delphine Groslambert, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems